title: Statins as adjunct therapy in COPD: how do we cope after STATCOPE?
authors.affiliation: School of Biological Science and the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
authors.forename: Robert P
authors.initials: RP
authors.lastname: Young
authors.affiliation: School of Biological Science and the Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
authors.forename: Raewyn J
authors.initials: RJ
authors.lastname: Hopkins
authors.affiliation: Thorax Institute, Hospital Clinic, IDIBAPS, University of Barcelona, and CIBERES, Madrid, Spain.
authors.forename: Alvar
authors.initials: A
authors.lastname: Agusti
mesh_terms: D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: COPD Exacerbations; COPD Pharmacology; COPD epidemiology; Cytokine Biology